<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41010833</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>18</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>A Randomized Controlled Trial of an Intelligent Cognitive Stimulation Program for Adults with ADHD: Study Protocol.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6629</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14186629</ELocationID><Abstract><AbstractText><b>Background</b>: Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood, causing substantial functional impairments. While pharmacological treatments are considered first-line, many adults either decline or do not benefit from medication, underscoring the need for effective non-pharmacological interventions. <b>Objective</b>: This study describes the protocol for a randomized controlled trial (RCT) evaluating Sincrolab Adults, an AI-based cognitive stimulation program for adults with ADHD. The primary objective is to determine whether 12 weeks of intervention improves cognitive performance. Secondary and exploratory objectives assess its impact on ADHD symptoms, quality of life, and durability of effect. <b>Methods</b>: The study will employ a single-blind, multicenter, randomized controlled design comparing the digital cognitive intervention to a treatment-as-usual control group. A total of 104 adults diagnosed with ADHD will be randomized to either the Sincrolab Adults program or the control group. Outcomes will be measured using the MOXO Continuous Performance Test (CPT) for cognitive performance, the Adult ADHD Self-Report Scale (ASRS) for symptoms, and the Adult ADHD Quality of Life (AAQoL) scale. A one-month post-intervention follow-up will assess persistence of effects. <b>Results</b>: The primary outcome will be improvement in the CPT total score. Secondary outcomes include reductions in the ASRS symptoms. Exploratory outcomes will examine quality of life, ADHD symptom subdomains, and durability of improvements. <b>Conclusions</b>: This study will provide evidence on the feasibility and preliminary efficacy of a digital cognitive stimulation platform for adults with ADHD. Findings could support the development of scalable, accessible treatment alternatives for individuals with ADHD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canadas</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1697-3440</Identifier><AffiliationInfo><Affiliation>Sincrolab, 28003 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestu</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3195-0071</Identifier><AffiliationInfo><Affiliation>Center for Cognitive and Computational Neuroscience, Departamento de Psicolog&#xed;a Experimental, Universidad Complutense de Madrid, 28015 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ramon</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-7828-6633</Identifier><AffiliationInfo><Affiliation>Sincrolab, 28003 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADHD</Keyword><Keyword MajorTopicYN="N">Adult</Keyword><Keyword MajorTopicYN="N">Digital therapeutics</Keyword><Keyword MajorTopicYN="N">clinical trial protocol</Keyword></KeywordList><CoiStatement>E.C. has received consultancy fees. F.M. serves as an advisor to the company. I.d.R. is the CEO of the company. The remaining author declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41010833</ArticleId><ArticleId IdType="pmc">PMC12471158</ArticleId><ArticleId IdType="doi">10.3390/jcm14186629</ArticleId><ArticleId IdType="pii">jcm14186629</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Polanczyk G.V., Salum G.A., Sugaya L.S., Caye A., Rohde L.A. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J. Child Psychol. Psychiatry. 2015;56:345&#x2013;365. doi: 10.1111/jcpp.12381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpp.12381</ArticleId><ArticleId IdType="pubmed">25649325</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;-L&#xf3;pez F., Hutton B., N&#xfa;&#xf1;ez-Beltr&#xe1;n A., Page M.J., Ridao M., Mac&#xed;as Saint-Gerons D., Catal&#xe1; M.A., Taba-r&#xe9;s-Seisdedos R., Moher D. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomized trials. PLoS ONE. 2017;12:e0180355. doi: 10.1371/journal.pone.0180355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180355</ArticleId><ArticleId IdType="pmc">PMC5507500</ArticleId><ArticleId IdType="pubmed">28700715</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayyad J., Sampson N.A., Hwang I., Adamowski T., Aguilar-Gaxiola S., Al-Hamzawi A., Andrade L.H.S.G., Borges G., Girolamo G., Florescu S., et al. The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys. Atten. Deficit Hyperact. Disord. 2017;9:47&#x2013;65. doi: 10.1007/s12402-016-0208-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12402-016-0208-3</ArticleId><ArticleId IdType="pmc">PMC5325787</ArticleId><ArticleId IdType="pubmed">27866355</ArticleId></ArticleIdList></Reference><Reference><Citation>Staley B.S., Robinson L.R., Claussen A.H., Katz S.M., Danielson M.L., Summers A.D., Farr S.L., Blumberg S.J., Tinker S.C. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults&#x2014;National Center for Health Statistics Rapid Surveys System, United States, October&#x2013;November 2023. MMWR Morb. Mortal. Wkly. Rep. 2024;73:890&#x2013;895. doi: 10.15585/mmwr.mm7340a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7340a1</ArticleId><ArticleId IdType="pmc">PMC11466376</ArticleId><ArticleId IdType="pubmed">39388378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirvikoski T., Lindholm T., Nordenstr&#xf6;m A., Nordstr&#xf6;m A.-L., Lajic S. High self-perceived stress and many stressors, but normal diurnal cortisol rhythm, in adults with ADHD. Horm. Behav. 2009;55:418&#x2013;424. doi: 10.1016/j.yhbeh.2008.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yhbeh.2008.12.004</ArticleId><ArticleId IdType="pubmed">19162030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjervan B., Torgersen T., Nordahl H.M., Rasmussen K. Functional impairment and occupational outcome in adults with ADHD. J. Atten. Disord. 2012;16:544&#x2013;552. doi: 10.1177/1087054711413074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054711413074</ArticleId><ArticleId IdType="pubmed">21725028</ArticleId></ArticleIdList></Reference><Reference><Citation>Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry. 2004;65:3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15046528</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkley R.A. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry. 2002;63:10&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12562056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhibber A., Watanabe A.H., Chaisai C., Veettil S.K., Chaiyakunapruk N. Global economic burden of attention-deficit/hyperactivity disorder: A systematic review. Pharmacoeconomics. 2021;39:399&#x2013;420. doi: 10.1007/s40273-020-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00998-0</ArticleId><ArticleId IdType="pubmed">33554324</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino M., Maravilla-Herrera P., Lorenzo T.M., Arance J.A., Bobes J., Corrales M., Guzm&#xe1;n F., Morales M., Mur C. The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain. Glob. Reg. Health Technol. Assess. 2024;11:82&#x2013;93. doi: 10.33393/grhta.2024.2697.</Citation><ArticleIdList><ArticleId IdType="doi">10.33393/grhta.2024.2697</ArticleId><ArticleId IdType="pmc">PMC11005448</ArticleId><ArticleId IdType="pubmed">38601072</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Mental Health ADHD: Attention-Deficit/Hyperactivity Disorder in Adults, U.S. Department of Health and Human Services.  [(accessed on 9 September 2025)]; Available online:  https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd.</Citation></Reference><Reference><Citation>Castells X., Blanco-Silvente L., Cunill R. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst. Rev. 2018;8:CD007813. doi: 10.1002/14651858.CD007813.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007813.pub3</ArticleId><ArticleId IdType="pmc">PMC6513464</ArticleId><ArticleId IdType="pubmed">30091808</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraone S.V., Glatt S.J. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J. Clin. Psychiatry. 2010;71:754&#x2013;763. doi: 10.4088/JCP.08m04902pur.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.08m04902pur</ArticleId><ArticleId IdType="pubmed">20051220</ArticleId></ArticleIdList></Reference><Reference><Citation>Advokat C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD) Neurosci. Biobehav. Rev. 2010;34:1256&#x2013;1266. doi: 10.1016/j.neubiorev.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2010.03.006</ArticleId><ArticleId IdType="pubmed">20381522</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuermaier A.B., Tucha L., Koerts J., Weisbrod M., Lange K.W., Aschenbrenner S., Tucha O. Effects of methylphenidate on memory functions of adults with ADHD. Appl. Neuropsychol. Adult. 2017;24:199&#x2013;211. doi: 10.1080/23279095.2015.1124108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2015.1124108</ArticleId><ArticleId IdType="pubmed">27088304</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese S., Adamo N., Giovane C., Mohr-Jensen C., Hayes A.J., Carucci S., Cipriani A. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. Lancet Psychiatry. 2018;5:727&#x2013;738. doi: 10.1016/S2215-0366(18)30269-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(18)30269-4</ArticleId><ArticleId IdType="pmc">PMC6109107</ArticleId><ArticleId IdType="pubmed">30097390</ArticleId></ArticleIdList></Reference><Reference><Citation>Brikell I., Yao H., Li L., Astrup A., Gao L., Gillies M.B., Chang Z. ADHD medication discontinuation and persistence across the lifespan: A retrospective observational study using population-based databases. Lancet Psychiatry. 2024;11:16&#x2013;26. doi: 10.1016/S2215-0366(23)00332-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(23)00332-2</ArticleId><ArticleId IdType="pubmed">38035876</ArticleId></ArticleIdList></Reference><Reference><Citation>Virta M., Vedenp&#xe4;&#xe4; A., Gr&#xf6;nroos N., Chydenius E., Partinen M., Vataja R., Kaski M., Iivanainen M. Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: A study of 29 participants. J. Atten. Disord. 2008;12:218&#x2013;226. doi: 10.1177/1087054707311657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054707311657</ArticleId><ArticleId IdType="pubmed">18192618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooij J.J.S., Bijlenga D., Salerno L., Jaeschke R., Bitter I., Bal&#xe1;zs J., Thome J., Dom G., Kasper S., Filipe C.N., et al. Updated European consensus statement on diagnosis and treatment of adult ADHD. Eur. Psychiatry. 2019;56:14&#x2013;34. doi: 10.1016/j.eurpsy.2018.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurpsy.2018.11.001</ArticleId><ArticleId IdType="pubmed">30453134</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  . Attention Deficit Hyperactivity Disorder: Diagnosis and Management (NICE Guideline NG87) National Institute for Health and Care Excellence; London, UK: 2018.  [(accessed on 9 September 2025)].  Available online:  https://www.nice.org.uk/guidance/ng87.</Citation></Reference><Reference><Citation>Stern A., Malik E., Pollak Y., Bonne O., Maeir A. The efficacy of computerized cognitive training in adults with ADHD: A randomized controlled trial. J. Atten. Disord. 2016;20:991&#x2013;1003. doi: 10.1177/1087054714529815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054714529815</ArticleId><ArticleId IdType="pubmed">24756172</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer-Smith M., Klingberg T. Benefits of a working memory training program for inattention in daily life: A systematic review and meta-analysis. PLoS ONE. 2015;10:e0119522. doi: 10.1371/journal.pone.0119522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119522</ArticleId><ArticleId IdType="pmc">PMC4368783</ArticleId><ArticleId IdType="pubmed">25793607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibe P., B&#xe4;cklund C., Vega-Mendoza M., S&#xf6;rman D., Malmberg Gavelin H., Nyberg L., Ljungberg J.K. Computerized cognitive interventions for adults with ADHD: A systematic review and meta-analysis. Neuropsychology. 2023;37:519&#x2013;530. doi: 10.1037/neu0000890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/neu0000890</ArticleId><ArticleId IdType="pubmed">36892894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabarron E., Denecke K., Lopez-Campos G. Evaluating the evidence: A systematic review of reviews of the effectiveness and safety of digital interventions for ADHD. BMC Psychiatry. 2025;25:414. doi: 10.1186/s12888-025-06825-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-025-06825-0</ArticleId><ArticleId IdType="pmc">PMC12016436</ArticleId><ArticleId IdType="pubmed">40264083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasi D., Volkow N.D. Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol. Psychiatry. 2012;71:443&#x2013;450. doi: 10.1016/j.biopsych.2011.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2011.11.003</ArticleId><ArticleId IdType="pmc">PMC3479644</ArticleId><ArticleId IdType="pubmed">22153589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucha L., Fuermaier A.B.M., Koerts J., Buggenthin R., Aschenbrenner S., Weisbrod M., Thome J., Lange K.W., Tucha O. Sustained attention in adult ADHD: Time-on-task effects of various measures of attention. J. Neural Transm. 2017;124:39&#x2013;53. doi: 10.1007/s00702-015-1426-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-015-1426-0</ArticleId><ArticleId IdType="pmc">PMC5281679</ArticleId><ArticleId IdType="pubmed">26206605</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcutt E.G., Doyle A.E., Nigg J.T., Faraone S.V., Pennington B.F. Validity of the executive function theory of ADHD: A meta-analytic review. Biol. Psychiatry. 2005;57:1336&#x2013;1346. doi: 10.1016/j.biopsych.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2005.02.006</ArticleId><ArticleId IdType="pubmed">15950006</ArticleId></ArticleIdList></Reference><Reference><Citation>Noreika V., Falter C.M., Rubia K. Timing deficits in ADHD: Evidence from neurocognitive and neuroimaging studies. Neuropsychologia. 2013;51:235&#x2013;266. doi: 10.1016/j.neuropsychologia.2012.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2012.09.036</ArticleId><ArticleId IdType="pubmed">23022430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonuga-Barke E.J.S., Brandeis D., Cortese S., Daley D., Ferrin M., Holtmann M. European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of RCTs of dietary and psychological treatments. Am. J. Psychiatry. 2013;170:275&#x2013;289. doi: 10.1176/appi.ajp.2012.12070991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2012.12070991</ArticleId><ArticleId IdType="pubmed">23360949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilan D.S., Chicchi Giglioli I.A., Cuesta P., Ca&#xf1;adas E., de Ram&#xf3;n I., Maest&#xfa; F., Alda J., Ramos-Quiroga J.A., Herrera J.A., Amado A., et al. Decreased impulsiveness and Meg normalization after AI-digital therapy in ADHD children: A RCT. NPJ Ment. Health Res. 2025;4:1. doi: 10.1038/s44184-024-00111-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44184-024-00111-9</ArticleId><ArticleId IdType="pmc">PMC11711623</ArticleId><ArticleId IdType="pubmed">39779908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xf3;n I., Pacios J., Medina R., Bouhaben J., Cuesta P., Ant&#xf3;n-Toro L., Quintero J., Quiroga A.R., Maest&#xfa; F. Alpha-band power increases in posterior brain regions in attention deficit hyperactivity disorder after digital cognitive stimulation treatment: Randomized controlled study. Brain Commun. 2022;4:fcac038. doi: 10.1093/braincomms/fcac038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac038</ArticleId><ArticleId IdType="pmc">PMC8984701</ArticleId><ArticleId IdType="pubmed">35402910</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina R., Bouhaben J., de Ram&#xf3;n I., Cuesta P., Ant&#xf3;n-Toro L., Pacios J., Quintero J., Ramos-Quiroga J.A., Maest&#xfa; F. Electrophysiological brain changes associated with cognitive improvement in a pediatric attention deficit hyperactivity disorder Digital Artificial Intelligence-driven intervention: Randomized controlled trial. J. Med. Internet Res. 2021;23:e25466. doi: 10.2196/25466.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25466</ArticleId><ArticleId IdType="pmc">PMC8665400</ArticleId><ArticleId IdType="pubmed">34842533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J., Anguera J.A., Gazzaley A. Video games for neuro-cognitive optimization. Neuron. 2016;90:214&#x2013;218. doi: 10.1016/j.neuron.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.010</ArticleId><ArticleId IdType="pubmed">27100194</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger I., Slobodin O., Cassuto H. Usefulness and validity of continuous performance tests in the diagnosis of attention-deficit/hyperactivity disorder children. Arch. Clin. Neuropsychol. 2017;32:81&#x2013;93. doi: 10.1093/arclin/acw101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acw101</ArticleId><ArticleId IdType="pubmed">28122767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler R.C., Adler L., Ames M., Demler O., Faraone S., Hiripi E., Walters E.E. The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol. Med. 2005;35:245&#x2013;256. doi: 10.1017/S0033291704002892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291704002892</ArticleId><ArticleId IdType="pubmed">15841682</ArticleId></ArticleIdList></Reference><Reference><Citation>Biederman J., Spencer T., Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 2024;7:77&#x2013;97. doi: 10.1017/S1461145703003973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1461145703003973</ArticleId><ArticleId IdType="pubmed">14733627</ArticleId></ArticleIdList></Reference><Reference><Citation>Brod M., Johnston J., Able S., Swindle R. Validation of the Adult Attention-Deficit/Hyperactivity Disorder Quality-of-Life Scale (AAQoL): A disease-specific quality-of-life measure. Qual. Life Res. 2006;15:117&#x2013;129. doi: 10.1007/s11136-005-8325-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-005-8325-z</ArticleId><ArticleId IdType="pubmed">16411036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum Associates; Hillsdale, NJ, USA: 1988.</Citation></Reference><Reference><Citation>Clinical Investigation of Medical Devices for Human Subjects&#x2014;Good Clinical Practice. ISO; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Rubin D.B. Multiple Imputation for Nonresponse in Surveys. John Wiley &amp; Sons; New York, NY, USA: 1987.</Citation></Reference><Reference><Citation>Kleim J.A., Jones T.A. Principles of experience-dependent neural plasticity: Implications for rehabilitation after brain damage. J. Speech Lang. Hear. Res. 2008;51:S225&#x2013;S239. doi: 10.1044/1092-4388(2008/018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/1092-4388(2008/018)</ArticleId><ArticleId IdType="pubmed">18230848</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>